Schilsky RL - Search Results

1

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ, Martino S, Ingle JN, Cooper MR, Hayes DF, Tkaczuk KH, Fleming G, Holland JF, Duggan DB, Carpenter JT, Frei E 3rd, Schilsky RL, Wood WC, Muss HB, Norton L. Henderson IC, et al. Among authors: schilsky rl. J Clin Oncol. 2003 Mar 15;21(6):976-83. doi: 10.1200/JCO.2003.02.063. J Clin Oncol. 2003. PMID: 12637460 Clinical Trial.

2

Antifolates: the next generation.

Fleming GF, Schilsky RL. Fleming GF, et al. Among authors: schilsky rl. Semin Oncol. 1992 Dec;19(6):707-19. Semin Oncol. 1992. PMID: 1462168 Review.

3

Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis.

Vokes EE, Schilsky RL, Weichselbaum RR, Kozloff MF, Panje WR. Vokes EE, et al. Among authors: schilsky rl. J Clin Oncol. 1990 Feb;8(2):241-7. doi: 10.1200/JCO.1990.8.2.241. J Clin Oncol. 1990. PMID: 1688926

4

Phase II study of echinomycin in patients with advanced breast cancer: a report of Cancer and Leukemia Group B protocol 8641.

Schilsky RL, Faraggi D, Korzun A, Vogelzang N, Ellerton J, Wood W, Henderson IC. Schilsky RL, et al. Invest New Drugs. 1991 Aug;9(3):269-72. doi: 10.1007/BF00176982. Invest New Drugs. 1991. PMID: 1783527 Clinical Trial.

5

Cytosine arabinoside and cisplatin for advanced breast cancer. A phase II study of the Cancer and Leukemia Group B.

Oster MW, Schilsky RL, Faraggi D, Korzun AH, Perry M, Moore A, Kalra J, Wood WC, Henderson IC. Oster MW, et al. Among authors: schilsky rl. Cancer. 1991 Oct 15;68(8):1696-8. doi: 10.1002/1097-0142(19911015)68:8<1696::aid-cncr2820680807>3.0.co;2-b. Cancer. 1991. PMID: 1913511 Clinical Trial.

6

Platinum-based combination chemotherapy in advanced non-small cell lung cancer: a randomized phase II trial of the Cancer and Leukemia Group B.

Green MR, Kramar A, Schilsky R, Stoopler M, Zimmer B, Richards F 2nd, Skarin A, Anderson JR. Green MR, et al. Med Pediatr Oncol. 1990;18(3):197-202. doi: 10.1002/mpo.2950180306. Med Pediatr Oncol. 1990. PMID: 2158614 Clinical Trial.

7

Clinical cardiotoxicity of esorubicin (4'-deoxydoxorubicin,DxDx): prospective studies with serial gated heart scans and reports of selected cases. A Cancer and Leukemia Group B report.

Ringenberg QS, Propert KJ, Muss HB, Weiss RB, Schilsky RL, Modeas C, Perry MC, Norton L, Green M. Ringenberg QS, et al. Among authors: schilsky rl. Invest New Drugs. 1990 May;8(2):221-6. doi: 10.1007/BF00177265. Invest New Drugs. 1990. PMID: 2166722

8

Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer.

Vokes EE, Choi KE, Schilsky RL, Moran WJ, Guarnieri CM, Weichselbaum RR, Panje WR. Vokes EE, et al. Among authors: schilsky rl. J Clin Oncol. 1988 Apr;6(4):618-26. doi: 10.1200/JCO.1988.6.4.618. J Clin Oncol. 1988. PMID: 3258629

9

Sequential hydroxyurea-cytarabine chemotherapy for refractory non-Hodgkin's lymphoma.

Schilsky RL, Williams SF, Ultmann JE, Watson S. Schilsky RL, et al. J Clin Oncol. 1987 Mar;5(3):419-25. doi: 10.1200/JCO.1987.5.3.419. J Clin Oncol. 1987. PMID: 3819808

10

Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study.

Miller AA, Hargis JB, Lilenbaum RC, Fields SZ, Rosner GL, Schilsky RL. Miller AA, et al. Among authors: schilsky rl. J Clin Oncol. 1994 Dec;12(12):2743-50. doi: 10.1200/JCO.1994.12.12.2743. J Clin Oncol. 1994. PMID: 7527456 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

374 results

Search Page